Web14 feb. 2024 · Ashfield Huntsworth is in market today with a $200 million add-on first-lien term loan, according to sources. A lender call is scheduled for 10 a.m. ET on Feb. 15, … Web30 jun. 2024 · Uniting the expertise and capabilities of Ashfield and Huntsworth, Inizio is a strategic partner for companies in health and life sciences. Connecting a full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services across the lifecycle of a drug, Inizio supports its partners from initial assessment …
Introducing Inizio: Ashfield and Huntsworth unite expertise to …
Web9 nov. 2024 · Corporate Development Director of Huntsworth / Ashfield the international Pharma Commercialisation business created by the merger of Huntsworth and UDG in August 2024. Prior to that Mr. Jones was Chief Operating Officer and Chief Financial Officer at Huntsworth PLC from February 2016. He joined Huntsworth Web29 jun. 2024 · Last spring it paid £575m for Huntsworth, a firm that helps drugmakers commercialise new therapies, and appointed its adviser Liam FitzGerald, a former chief executive of UDG, as chairman. trilby hat women
CD&R on partnership investing at scale - Private Equity International
Web7 jul. 2024 · Huntsworth had 50 offices across 28 countries at the time of acquisition. As CD&R ramped up its targeting of healthcare industry companies during the pandemic (especially in the Brexit-devalued UK&I … WebHuntsworth and Ashfield rebrand health business as Inizio. Ashfield and Huntsworth have rebranded their combined health and life science operations, including the PR business Evoke, under a new name: Inizio. by John Harrington. Sign in to continue. Sign in. Sign in. Email address. Password. Web30 jun. 2024 · ‘Probably the largest drug launch company on the planet’: Huntsworth/Ashfield union spawns Inizio The newly merged organization … terry naylor solar panels